Zhu Y, Kim S, Chen Z, Will R, Zhong R, Dammann P
Cells. 2024; 13(17.
PMID: 39273014
PMC: 11394141.
DOI: 10.3390/cells13171442.
Zhou Q, Breitkopf-Heinlein K, Gaitantzi H, Birgin E, Reissfelder C, Rahbari N
Clin Sci (Lond). 2024; 138(18):1111-1129.
PMID: 39212293
PMC: 11405861.
DOI: 10.1042/CS20240450.
Ni W, Leng X
Spinal Cord. 2023; 62(3):99-103.
PMID: 38158408
DOI: 10.1038/s41393-023-00952-9.
Liu J, Zhao K, Wu S, Li C, You C, Wang J
Cancers (Basel). 2022; 14(23).
PMID: 36497468
PMC: 9740655.
DOI: 10.3390/cancers14235986.
Liu J, Wang J, Tian W, Xu Y, Li R, Zhao K
Aging (Albany NY). 2022; 14(15):6066-6080.
PMID: 35963638
PMC: 9417224.
DOI: 10.18632/aging.204206.
Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.
Phillips C, Stamatovic S, Keep R, Andjelkovic A
Int J Mol Sci. 2022; 23(9).
PMID: 35563390
PMC: 9105545.
DOI: 10.3390/ijms23095000.
The multifaceted gene.
Valentino M, Dejana E, Malinverno M
Genes Dis. 2021; 8(6):798-813.
PMID: 34522709
PMC: 8427250.
DOI: 10.1016/j.gendis.2020.12.008.
Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation.
Sun B, Zhong F, Xu C, Li Y, Zhao Y, Cao M
Cell Death Dis. 2021; 12(9):849.
PMID: 34521817
PMC: 8440642.
DOI: 10.1038/s41419-021-04139-z.
Down-regulated miR-495 can target programmed cell death 10 in ankylosing spondylitis.
Ni W, Leng X
Mol Med. 2020; 26(1):50.
PMID: 32450789
PMC: 7249445.
DOI: 10.1186/s10020-020-00157-3.
Effects of programmed cell death protein 10 on fecundity in Schistosoma japonicum.
Gao Y, Xu J, Tang C, Cai Z, Wu Q, Xiong Y
Parasitol Res. 2020; 119(4):1317-1325.
PMID: 32152713
DOI: 10.1007/s00436-020-06635-1.
Cerebral Cavernous Malformation Proteins in Barrier Maintenance and Regulation.
Wei S, Li Y, Polster S, Weber C, Awad I, Shen L
Int J Mol Sci. 2020; 21(2).
PMID: 31968585
PMC: 7013531.
DOI: 10.3390/ijms21020675.
The Molecular Evolution and Functional Divergence of Lamprey Programmed Cell Death Genes.
Guan X, Lu J, Sun F, Li Q, Pang Y
Front Immunol. 2019; 10:1382.
PMID: 31281315
PMC: 6596451.
DOI: 10.3389/fimmu.2019.01382.
Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening.
Schwefel K, Spiegler S, Ameling S, Much C, Pilz R, Otto O
J Cell Mol Med. 2018; 23(3):1771-1783.
PMID: 30549232
PMC: 6378188.
DOI: 10.1111/jcmm.14075.
Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
Nickel A, Wan X, Saban D, Weng Y, Zhang S, Keyvani K
J Neurooncol. 2018; 141(1):31-41.
PMID: 30392087
DOI: 10.1007/s11060-018-03017-7.
Influence of Schistosoma japonicum programmed cell death protein 10 on the growth and development of schistosomula.
Gao Y, Huang W, Tang C, Liu R, Zhao Q, Ming Z
Parasit Vectors. 2018; 11(1):46.
PMID: 29347959
PMC: 5774102.
DOI: 10.1186/s13071-018-2636-8.
miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
Yang D, Wang J, Li J, Xu Q
Oncol Res. 2017; 26(4):519-528.
PMID: 28734041
PMC: 7844823.
DOI: 10.3727/096504017X15000757094686.
STRIPAK complexes in cell signaling and cancer.
Shi Z, Jiao S, Zhou Z
Oncogene. 2016; 35(35):4549-57.
PMID: 26876214
DOI: 10.1038/onc.2016.9.
MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10.
Zhang Y, Hu X, Miao X, Zhu K, Cui S, Meng Q
J Cell Mol Med. 2015; 20(2):360-9.
PMID: 26647742
PMC: 4727563.
DOI: 10.1111/jcmm.12742.
Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.
Lambertz N, El Hindy N, Kreitschmann-Andermahr I, Stein K, Dammann P, Oezkan N
BMC Cancer. 2015; 15:759.
PMID: 26490252
PMC: 4618952.
DOI: 10.1186/s12885-015-1709-8.
Differential expression of MST4, STK25 and PDCD10 between benign prostatic hyperplasia and prostate cancer.
Zhang H, Ma X, Peng S, Nan X, Zhao H
Int J Clin Exp Pathol. 2015; 7(11):8105-11.
PMID: 25550858
PMC: 4270628.